FORTRESS BIOTECH INC - COM (FBIO)

CUSIP: 34960Q109

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
31,748,690
Share change
+1,878,703
Total reported value
$79,363,187
Put/Call ratio
148%
Price per share
$2.50
Number of holders
78
Value change
+$4,365,775
Number of buys
37
Number of sells
33

Quarterly Holders Quick Answers

What is CUSIP 34960Q109?
CUSIP 34960Q109 identifies FBIO - FORTRESS BIOTECH INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FORTRESS BIOTECH INC - COM (FBIO) as of Q4 2021

As of 31 Dec 2021, FORTRESS BIOTECH INC - COM (FBIO) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,748,690 shares. The largest 10 holders included Nantahala Capital Management, LLC, VANGUARD GROUP INC, BlackRock Inc., Opaleye Management Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, SHIKIAR ASSET MANAGEMENT INC, NORTHERN TRUST CORP, JACOBS LEVY EQUITY MANAGEMENT, INC, and Bank of New York Mellon Corp. This page lists 78 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.